Tresiba FlexTouch Insulin Pen from Japan
Tresiba FlexTouch provides ultra-long-acting insulin degludec for diabetes basal insulin therapy. Available in U100 (3mL, 100 units/mL) and U200 (3mL, 200 units/mL) pre-filled pens with measured dosing. Falls under HTS 3004.31.00.00 as retail-packaged insulin medicaments.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Dual concentration variants need separate line items with precise strength declaration
• EU COS certificates essential for insulin biologics import
• Pen needle compatibility docs prevent device reclassification